• MiniMed Group, Inc. is trading at $14.12 (4.4%) down in pre-market, giving back a portion of last week’s gains after a stretch of choppy trading.
  • The move follows the June 17, 2026, U.S. launch of the MiniMed Flex app-controlled insulin pump, a major product event that remains the primary catalyst for the stock.
  • There are no fresh headlines or analyst calls driving the price action this morning, suggesting a consolidation of recent gains.